Happy to announce this new publication about mNeonGreen 💚 and sfTq2ox 💙 expression in the cytoplasm of E. coli.
Congratulations to the authors @TannekedenBlaau and @LaureenMertens from @SILS_UvA !
https://t.co/jWSoSrF0th
We are proud to share the latest @train2target paper from our #ESR Federico Corona
In this paper, the authors explore the crosstalk between #OMP biogenesis and #peptidoglycan maturation
Congratulations to al the authors!! Vollmer lab @KleanthousLab
https://t.co/1DkN62cxbl
The peptidoglycan of Akkermansia contains non-acetylated glucosamine (GlcNH2) which has not been described as a major component of gram-negative PG before!
It activates NOD1 & NOD2 receptors leading to a similar immune response as to E. coli.
We are proud of @Train2Target's Carina Matias (@CarinaSofiaM) contributions to this paper!
The paper explores the potential of topical niclosamide ATx201 as a decolonizing agent.
Congratulations to all the authors 👏👏
https://t.co/XgIJ75zyJ4
We're very happy to showcase this work by
@Train2Target's Elisa Consoli, @TannekedenBlaau'wen
and their collaborator Joen Luirink. 👏👏👏
'The Escherichia coli Outer Membrane β-Barrel Assembly Machinery (BAM) Crosstalks with the Divisome.'
https://t.co/fY3L58QErb
Proud to share this publication by @Train2Target ESRs @TiagoBaeta7, Elisabete Moura and their colleagues.
The lipopolysaccharide transporter complex LptB2FG also displays adenylate kinase activity in vitro dependent on binding partners LptC/LptA
https://t.co/47HGrolmqG
Oral admin of pasteurised Akkermansia muciniphila is safe, the European Authority of Food Safety @EFSA_EU said!
This is a crucial step towards new generation nutritional supplements to treat #diabetes and other metabolic diseases.
It's also part of my PhD!
https://t.co/a6dYXjt7s0
We are happy to announce this paper from @Train2Target ESR @JessicaelRayes1 and her colleagues. Congratulations to all the authors! 🥳
'Disorder is a critical component of lipoprotein sorting in Gram-negative bacteria.'
https://t.co/qH8rPYiNRm
Happy to announce our last paper: how disorder controls lipoprotein targeting. Congrats @JessicaelRayes1 queen of the ultracentrifuge :) beautiful work, journey with @MichaelDeghelt@IorgaBI@bluegreen812@NaemiC thanks @Welbio_asbl @UCLouvain_be @frsFNRS https://t.co/Pa5iTlcmpj
Happy to share this preprint on @biorxiv_micrbio:
'LptB2FG is an ABC transporter with Adenylate Kinase activity regulated by LptC/A recruitment.'
A collaboration between our ESRs @TiagoBaeta7, Elisabete Moura and their colleagues in Grenoble and Milan.
https://t.co/lsZVLn3WTI
Congratulations Raquel ! You have done a terrific work Dr Rodriguez Alonso ! We were all impressed by the high level discussion you had with the jury members. Good luck with your next step ! We will miss you. Thank you to @Train2Target
Very happy to announce this new publication involving work by @Train2Target's Federico Corona and Prof. Waldemar Vollmer.
Combining Cell Envelope Stress Reporter Assays in a Screening Approach to Identify BAM Complex Inhibitors
https://t.co/lZnSiB3ter
Congratulations to @Train2Target and @AiCuris researcher @AranchaLopezPe1 for successfully defending her PhD thesis 'A target-based approach to identify scaffolds for developing novel PBP inhibitors' at Newcastle University!
💐👏💐👏💐👏💐
Very happy to announce this publication by @AranchaLopezPe1 and colleagues in @antibioticsmdpi
Discovery of Pyrrolidine-2,3-diones as Novel Inhibitors of P. aeruginosa PBP3.
https://t.co/JP8L8eouTn